YM155 potently triggers cell death in breast cancer cells through an autophagy-NF-kB network - Archive ouverte HAL Access content directly
Journal Articles Oncotarget Year : 2015

YM155 potently triggers cell death in breast cancer cells through an autophagy-NF-kB network

(1) , (1) , (1, 2) , (1) , (1, 3) , (1, 3) , (1)
1
2
3

Abstract

Specific overexpression in cancer cells and evidence of oncogenic functions make Survivin an attractive target in cancer therapy. The small molecule compound YM155 has been described as the first "Survivin suppressant" but molecular mechanisms involved in its biological activity and its clinical potential remain obscure. We herein show that YM155 exerts single agent toxicity on primary breast cancer cells grown in an ex vivo assay preserving tumor microenvironment. In vitro assays indicate that YM155 more efficiently triggers cell death in breast cancer cells (including these with stem-cell like properties) than in non tumorigenic mammary cells. YM155-induced cell death is critically dependent on autophagy and NF-kB but independent of p53 and it coïncides with DNA damage and a DNA damage response in p53-proficient cells. Our results point out a crosstalk between NF-kB and autophagy controlling YM155-induced death in breast cancer cells and argue for the potential use of YM155 as a genotoxic agent in breast cancer therapy.
Fichier principal
Vignette du fichier
VequaudOncotarget2015.pdf (3.46 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Loading...

Dates and versions

inserm-01817979 , version 1 (18-06-2018)

Identifiers

Cite

Eloïse Véquaud, Céline Séveno, Delphine Loussouarn, Lucie Engelhart, Mario Campone, et al.. YM155 potently triggers cell death in breast cancer cells through an autophagy-NF-kB network. Oncotarget, 2015, 6 (15), pp.13476-86. ⟨10.18632/oncotarget.3638⟩. ⟨inserm-01817979⟩
43 View
82 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More